Abstract

Channelrhodopsin-2 (ChR2)-based optogenetic technique has been increasingly applied to cardiovascular research. However, the potential effects of ChR2 protein overexpression on cardiomyocytes are not completely understood. The present work aimed to examine how the doxycycline-inducible lentiviral-mediated ChR2 expression may affect cell viability and electrophysiological property of neonatal rat ventricular myocyte (NRVM) cultures. Primary NVRMs were infected with lentivirus containing ChR2 or YFP gene and subjected to cytotoxicity analysis. ChR2-expressing cultures were then paced electrically or optically with a blue light-emitting diode, with activation spread recorded simultaneously using optical mapping. Results showed that ChR2 could be readily transduced to NRVMs by the doxycycline-inducible lentiviral system; however, high-level ChR2 (but not YFP) expression was associated with substantial cytotoxicity, which hindered optical pacing. Application of bromodeoxyuridine significantly reduced cell damage, allowing stimulation with light. Simultaneous optical Vm mapping showed that conduction velocity, action potential duration, and dVm/dtmax were similar in ChR2-expressing and control cultures. Finally, the ChR2-expressing cultures could be optically paced at multiple sites, with significantly reduced overall activation time. In summary, we demonstrated that inducible lentiviral-mediated ChR2 overexpression might cause cytotoxicity in NRVM cultures, which could be alleviated without impairing electrophysiological function, allowing simultaneous optical pacing and Vm mapping.

Highlights

  • Alternative methods for genetic manipulation, e.g., viral vector-based delivery of optogenetic constructs into cells or tissue of non-transgenic diseased hearts

  • We examined whether BrdU treatment enables direct optical pacing of cardiomyocytes containing Doxy-inducible ChR2 expression

  • We developed and characterized an optogenetic neonatal rat ventricular myocyte (NRVM) culture model that is based on Doxy-inducible ChR2 expression

Read more

Summary

Introduction

Alternative methods for genetic manipulation, e.g., viral vector-based delivery of optogenetic constructs into cells or tissue of non-transgenic diseased hearts. Lentiviruses have been extensively used as gene delivery vectors since the mid-1990s Due to their ability to integrate into the genome of target cells, lentiviruses can infect both dividing and non-dividing cells and confer stable high-level expression[18]. This characteristic renders them of vital interest for gene therapy of cancer, cardiovascular disease, infectious disease, and neurodegenerative diseases. Their work primarily focused on the light-induced modulation of action potential duration (APD) To address those issues, we developed and characterized an optogenetic NRVM culture model containing doxycycline (Doxy)-inducible lentiviral-mediated ChR2 expression. Preliminary results of this work have been published in abstract form[31]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call